TruNativ's Revenue Soars 2.3x as Sugar-Free Nutraceuticals Win Loyal Customers

TruNativ, a science-backed nutraceutical brand, has seen rapid growth since its launch in 2019. Founded by Mamta and Pranav Malhotra alongside Eeshaan Merchant, the company focuses on ingredient-first products designed to cut sugar while boosting protein and fibre. Recent financial figures show a sharp rise in revenue, with the brand now targeting even higher sales by the end of 2025.

The company's revenue jumped 2.3 times in FY25, climbing from INR 16.59 Cr in FY24 to INR 37.73 Cr. By November 2025, TruNativ had already surpassed INR 65 Cr in earnings, setting a full-year target of INR 115-120 Cr. A significant portion of its direct-to-consumer (D2C) sales—47%—comes from repeat customers, reflecting strong brand loyalty.

TruNativ operates on an asset-light model, partnering with specialists like Fermentis Life Sciences and Manisha Pharmo Plast for manufacturing. No new supplier collaborations have been publicly announced in the last two years. Its flagship products, including Everyday Sweet, Everyday Fiber, and Advanced Collagen Peptides, cater to consumers looking to improve nutrition without altering daily eating habits.

The brand's growth aligns with broader market trends. Functional foods and beverages dominated India's nutraceuticals sector in 2024, holding a 49.2% share. With the country's nutrition and supplement market expected to reach $68.4 billion by 2030, TruNativ plans to expand its offline retail and quick-commerce presence. New science-backed products are also slated for release within the next 12-18 months.

TruNativ's revenue surge and customer retention highlight its position in India's expanding nutraceuticals market. The company's focus on sugar reduction and protein enrichment, combined with strategic manufacturing partnerships, supports its growth trajectory. Further expansion into retail and product innovation will shape its next phase of development.